PMDA drug package insert
アイザベイ硝子体内注射液20mg/mL
PMDA Prescription drug · アステラス製薬株式会社 · package insert Nov 27, 2025
Key facts
| Brand names | アイザベイ硝子体内注射液20mg/mL |
|---|---|
| Nonproprietary names | アバシンカプタド ペゴルナトリウム |
| Companies | 製造販売／アステラス製薬株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 眼科用補体第5成分阻害薬／ポリエチレングリコール共役RNAアプタマー |
| Therapeutic category codes | 871319 |
| YJ codes | 1319409A1025 |
| Approval numbers | 30700AMX00242 |
| Package insert edition | 第2版 |
| Package insert date | Nov 27, 2025 |
| PMDA document key | 800126_1319409A1025_1 |
| PMDA company code | 800126 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- Yes Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: